Pharmuny SA
2.4 FTEThe score of Pharmuny shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +37 % Total assets -19 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmuny's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 121,007 € | ||||
| Equity | 309,069 € | ||||
| Cash | 235,447 € | ||||
| EBITDA | 240,169 € | ||||
| Total assets | 909,631 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jun 2023
- Year ended 31 Dec 2021filed on 01 Jul 2022
Pharmuny's financial analysis
- Solvency34.0%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmuny
Pharmuny's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0443.874.077
- VAT number
- BE0443874077
- Peppol
- Registered · 0208:0443874077 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 05 Apr 1991
- Registered office
- 7890 Ellezelles
- Size
- Micro · 2.4 FTE
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmuny (SA) has been based in Ellezelles since 1991, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 121,007 € and equity of 309,069 €; its revenue is not published. With 2.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 34.0%, below the median of its sector (41.5%).
Companies similar to Pharmuny
Companies in the same business, of comparable size and area, outside its group.
- Apotheek VAN Besien Retail sale of pharmaceutical products Nieuwpoort · balance sheet 909,462 €
- Pharmanema Retail sale of pharmaceutical products Leuven · balance sheet 910,021 €
- Novil'Pharma Retail sale of pharmaceutical products Fernelmont · balance sheet 907,966 €
- Pharmacie des Câbleries Retail sale of pharmaceutical products Dour · balance sheet 907,567 €
- Pharma Tilleul Retail sale of pharmaceutical products Montigny-le-Tilleul · balance sheet 912,565 €
- Propharma Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet 915,541 €
- Pharmayou Glons Retail sale of pharmaceutical products Bassenge · balance sheet 901,766 €
- Holsbeek Deurne Retail sale of pharmaceutical products Antwerp · balance sheet 917,585 €
Frequently asked questions about Pharmuny
What is the revenue of Pharmuny?
Pharmuny files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmuny?
In Belgium, the VAT number is the company number prefixed with BE: BE0443874077 for Pharmuny, if the company is VAT-registered. Its company number (CBE) is 0443.874.077.
Where is the registered office of Pharmuny?
According to the CBE register, the registered office of Pharmuny is in 7890 Ellezelles.
What is the equity of Pharmuny?
At the close of the 2025 financial year, the equity of Pharmuny amounts to 309,069 €, a solvency of 34.0% of total assets.
How many people work at Pharmuny?
2.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmuny?
The register lists 7 active mandates at Pharmuny. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmuny
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →